KOSELUGO (selumetinib) is the FIRST and ONLY FDA-approved prescription medicine that is used to treat children 2 years of age and older with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas that cannot be completely removed by surgery. It is not known if Koselugo is safe and effective in children under 2 years of age.

Koselugo is proven to reduce the size of plexiform neurofibromas (PN).*

Learn more

*66% of patients saw a 20% or more decrease in the size of their plexiform neurofibromas, confirmed by 3D magnetic resonance imaging scan.

Get Koselugo Support

 

For personalized Koselugo support, call 1-844-ASK-A360 (1-844-275-2360)1-844-ASK-A360 (1-844-275-2360) or visit www.MyAccess360.com.

Important Safety Inforamtion